Our News on Newswise

Newswise: 62fd3294a1870_JACCLongCOVIDHeart.jpg

Reduced myocardial blood flow is new clue in how COVID-19 is impacting the heart

Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist. This finding offers a new clue in understanding...
17-Aug-2022 2:45 PM EDT Add to Favorites

A new way to control pain after knee replacement surgery

Houston Methodist researchers present clinical evidence supporting the safety and efficacy of injecting pain medication directly into the tibia during knee replacement surgery for better postoperative pain management. The study revealed patients...
12-Aug-2022 2:05 PM EDT Add to Favorites

Houston Methodist study finds new chronic rhinitis treatment could be game changer

A new study at Houston Methodist shows that that a new temperature-controlled radiofrequency intervention is a safe and effective way to improve symptoms of chronic rhinitis. Chronic rhinitis involves symptoms such as a near constant runny nose,...
4-Aug-2022 5:05 PM EDT Add to Favorites

COVID-19 infection in crucial brain regions may lead to accelerated brain aging

We all know that people have reported brain fog and other neurological issues after having COVID-19. But a new study shows some sobering news – COVID-19 infections may have serious long-term effects. Major findings include that COVID-19 infections...
4-Aug-2022 2:50 PM EDT Add to Favorites

Stranger Things may be fiction, but music really is medicine

30-Jun-2022 12:05 PM EDT Add to Favorites

Study Reveals How Omicron Variants Escape Immune System to Become So Contagious

A new Houston Methodist study explains clever ways the BA.1 and BA.2 omicron variants escape antibodies, contributing to the ability of these variants to spread rapidly and to be so successful in infecting people with the COVID-19 virus. Knowing...
21-Apr-2022 1:05 PM EDT Add to Favorites

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

.A drug used to treat cardiac failure has shown promising results in treating triple negative breast cancer, according to Houston Methodist researchers who released results this week on a new combined therapy with the potential to improve outcomes...
15-Dec-2021 5:05 PM EST Add to Favorites

Houston Methodist receives $25 million to expand cancer center

Houston Methodist has received a $25 million philanthropic gift from Dr. Mary and Ron Neal to expand the hospital system’s cancer center.
19-Nov-2021 10:00 AM EST Add to Favorites

See All News

Our Experts on Newswise

Don’t lose sleep over daylight saving time

11-Mar-2022 1:30 PM EST

Houston Methodist experts on J&J vaccine announcement

24-Feb-2021 10:10 AM EST

Houston Methodist expert notes COVID-19 precautions lead to historic drop in flu cases

A silver lining is emerging amid the COVID-19 pandemic. Influenza numbers are way down – 98 percent down, according to the CDC. Locally, during flu season last year, Houston Methodist’s system of eight hospitals saw 250 to 450 flu cases per...
2-Feb-2021 2:30 PM EST

Principal Investigator for COVID-19 drug with FDA Emergency Use Authorization available to speak on limited government supply of drug and pending clinical trials

17-Nov-2020 1:05 PM EST

Newswise: 628d56db15ece_HeadshotCookeJohnDSC03713.jpg

Messenger RNA – the Therapy of the Future

16-Nov-2020 10:40 AM EST

Newswise: geyer-charles-1891795001.jpg

Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19

24-Jun-2020 10:10 AM EDT

Newswise: sitecore-web-drmassud-hmac-sm.ashx?mw=1382&hash=B06C6FC7E006DF1BBCEC37714756A733.jpg

Research and innovation as an essential function amid the COVID-19 pandemic

Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has...
29-Apr-2020 12:10 PM EDT

Newswise: Kash_Bita_220x250.jpg

Bita Kash, PhD, Researcher with Houston Methodist, available to discuss COVID-19 and African American communities

20-Apr-2020 2:30 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.


U.S. News & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine’s biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey’s achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.



Stefanie Asin
Public Relations Director
Corporate Communications



Gale Smith
Public Relations Manager
Research Institute, Gastroenterology & GI Surgery, Ophthalmology, Otolaryngology/ENT



Lisa Merkl
Senior Research Media Relations Editor
Research Institute



Ashley White
Public Relations Program Manager
Cancer Center, Transplant Center



Patti Muck
Public Relations Program Manager
Neurological Institute, Emergency Medicine



Rodney Evans
Senior Marketing & Communications Specialist



Amy Rose
Senior Media Relations Specialist
Heart Center, Orthopedics & Sports Medicine